CLASS ACTION UPDATE for TILE, NERV and QIWI: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

This post was originally published on this site

The MarketWatch News Department was not involved in the creation of this content.

January 08, 2021 (ACCESSWIRE via COMTEX) — NEW YORK, NY / ACCESSWIRE / January 8, 2021 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the court. Further details about the cases can be found at the links provided. There is no cost or obligation to you.

TILE Shareholders Click Here: https://www.zlk.com/pslra-1/interface-inc-loss-submission-form?prid=12026&wire=1

NERV Shareholders Click Here: https://www.zlk.com/pslra-1/minerva-neurosciences-inc-loss-submission-form?prid=12026&wire=1

QIWI Shareholders Click Here: https://www.zlk.com/pslra-1/qiwi-plc-information-request-form?prid=12026&wire=1

* ADDITIONAL INFORMATION BELOW *

Image: https://www.accesswire.com/users/newswire/images/623600/image-20210108104230-1.png

Interface, Inc. (NASDAQ:TILE)

TILE Lawsuit on behalf of: investors who purchased March 2, 2018 – September 28, 2020

Lead Plaintiff Deadline : January 11, 2021

TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/interface-inc-loss-submission-form?prid=12026&wire=1

According to the filed complaint, during the class period, Interface, Inc. made materially false and/or misleading statements and/or failed to disclose that: (i) Interface had inadequate disclosure controls and procedures and internal control over financial reporting; (ii) consequently, Interface, inter alia, reported artificially inflated income and earnings per share (“EPS”) in 2015 and 2016; (iii) Interface and certain of its employees were under investigation by the SEC with respect to the foregoing issues since at least as early as November 2017, had impeded the SEC’s investigation, and downplayed the true scope of the Company’s wrongdoing and liability with respect to the SEC investigation; and (iv) as a result, the Company’s public statements were materially false and misleading at all relevant times.

Minerva Neurosciences, Inc. (NASDAQ:NERV)

NERV Lawsuit on behalf of: investors who purchased May 15, 2017 – November 30, 2020

Lead Plaintiff Deadline : February 8, 2021

TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/minerva-neurosciences-inc-loss-submission-form?prid=12026&wire=1

According to the filed complaint, during the class period, Minerva Neurosciences, Inc. made materially false and/or misleading statements and/or failed to disclose that: (i) the truth about the feedback received from the FDA concerning the “end-of-Phase 2” meeting; (ii) the Phase 2b study did not use the commercial formulation of roluperidone and was conducted solely outside of the United States; (iii) the failure of the Phase 3 study to meet its primary and key secondary endpoints rendered that study incapable of supporting substantial evidence of effectiveness; (iv) the Company’s plan to use the combination of the Phase 2b and Phase 3 studies would be “highly unlikely” to support the submission of an NDA; (v) reliance on these two trials in the submission of an NDA would lead to “substantial review issues” because the trials were inadequate and not well-controlled; and (vi) as a result, the Company’s public statements were materially false and misleading at all relevant times.

Qiwi plc (NASDAQ:QIWI)

QIWI Lawsuit on behalf of: investors who purchased March 28, 2019 – December 9, 2020

Lead Plaintiff Deadline : February 9, 2021

TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/qiwi-plc-information-request-form?prid=12026&wire=1

According to the filed complaint, during the class period, Qiwi plc made materially false and/or misleading statements and/or failed to disclose that: (1) Qiwi’s internal controls related to reporting and record-keeping were ineffective; (2) consequently, the Central Bank of Russia would impose a monetary fine upon the Company and impose restrictions upon the Company’s ability to make payments to foreign merchants and transfer money to pre-paid cards; and (3) as a result, Defendants’ public statements were materially false and/or misleading at all relevant times.

You have until the lead plaintiff deadlines to request that the court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

Levi & Korsinsky is a nationally recognized firm with offices in New York, California, Connecticut, and Washington D.C. The firm’s attorneys have extensive expertise and experience representing investors in securities litigation and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com

SOURCE: Levi & Korsinsky, LLP

View source version on accesswire.com:

https://www.accesswire.com/623600/CLASS-ACTION-UPDATE-for-TILE-NERV-and-QIWI-Levi-Korsinsky-LLP-Reminds-Investors-of-Class-Actions-on-Behalf-of-Shareholders

COMTEX_377399555/2457/2021-01-08T11:01:01

Is there a problem with this press release? Contact the source provider Comtex at editorial@comtex.com. You can also contact MarketWatch Customer Service via our Customer Center.

Copyright 2021 ACCESSWIRE

The MarketWatch News Department was not involved in the creation of this content.